Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia

[1]  S. Karlsson,et al.  Disruption of the 5S RNP–Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia , 2015, Leukemia.

[2]  S. Soneji,et al.  Hematopoietic Stem Cells Are Intrinsically Protected Against MLL-ENL Mediated Transformation , 2014 .

[3]  A. Schambach,et al.  Gene therapy cures the anemia and lethal bone marrow failure in a mouse model of RPS19-deficient Diamond-Blackfan anemia , 2014, Haematologica.

[4]  R. Coleman,et al.  Ribosomal protein–Mdm2–p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation , 2014, Proceedings of the National Academy of Sciences.

[5]  Jeffrey A. Magee,et al.  Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.

[6]  M. Bohnsack,et al.  The 5S RNP Couples p53 Homeostasis to Ribosome Biogenesis and Nucleolar Stress , 2013, Cell reports.

[7]  S. Peddigari,et al.  5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. , 2013, Cell reports.

[8]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[9]  Jiwang Zhang,et al.  Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. , 2012, Cancer cell.

[10]  Carleen Cullinane,et al.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. , 2012, Cancer cell.

[11]  P. Rosenberg,et al.  Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. , 2012, Blood.

[12]  A. Schambach,et al.  Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. , 2011, Blood.

[13]  Yanping Zhang,et al.  The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. , 2011, Genes & cancer.

[14]  R. Pearson,et al.  Signaling to the ribosome in cancer—It is more than just mTORC1 , 2011, IUBMB life.

[15]  K. Bhat,et al.  An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. , 2010, Cancer cell.

[16]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Hsieh,et al.  MLL fusions: Pathways to leukemia , 2009, Cancer biology & therapy.

[18]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[19]  Davide Ruggero,et al.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.

[20]  S. Karlsson,et al.  Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference , 2008, British journal of haematology.

[21]  J. Hess,et al.  MLL associates specifically with a subset of transcriptionally active target genes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Pandolfi,et al.  Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[23]  M. E. Perry,et al.  mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation , 2003, Molecular and Cellular Biology.

[24]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[25]  L. Kömüves,et al.  Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias , 1999, Leukemia.

[26]  Peter Gustavsson,et al.  The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia , 1999, Nature Genetics.

[27]  Unnur Thorsteinsdottir,et al.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.

[28]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[29]  R. Berger,et al.  Mutations of the P53 gene in acute myeloid leukaemia , 1992, British journal of haematology.

[30]  S. Karlsson,et al.  Disruption of the 5 S RNP-Mdm 2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia , 2015 .

[31]  E. Lander,et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.